Detact Diagnostics is a privately owned Dutch company founded in 2014 that has developed a patented, novelle and disruptive bacterial detection platform technology. This new way to detect unwanted bacteria is highly sensitive, specific, affordable, fast and lends itself for point of care use. The company brought its pioneer products to market, the Enzotact©Pro (a protease-test) and the DeNIRO© Fluorometer, and is currently developing additional applications for the healthcare and food safety markets. EXITED.
